Guang Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Guang Li has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Jonathan Quincy Brown
Department of Biomedical Engineering, Tulane University, New Orleans, USA
4 shared publications Aibek Akmatbekov
LSU Health Sciences Center - New Orleans
2 shared publications- Bihe Hu
Tulane University, Department of Biomedical Engineering, New Orleans, Louisiana
2 shared publications Jack L. Harbert
LSU Health Sciences Center - New Orleans
2 shared publications- Richard S. Vander Heide
Department of Pathology, Louisiana State University Health Sciences Center, New Orleans, LA
2 shared publications - Sharon E. Fox
Southeast Louisiana Veterans Healthcare System, New Orleans, USA
2 shared publications
Latest Publications
- 1 January 2023
- Published by Optica Publishing Group
- p. NTu1C.3
Optimizing Imaging Throughput and Resolution in Light Sheet Microscopy Using Deep-learning-based Beam Shape Translation
A conditional generative adversarial network (cGAN) approach to optimize resolution or contrast and field-of-view (FOV) in beam-scanned light sheet microscopy by beam shape translation is demonstrated. Large FOV images acquired with collimated (pencil) beam (weakly-focused) illumination are used to predict large FOV, but higher contrast, images mimicking Gaussian-beam (highly focused) illumination. In this way, imaging throughput and resolution is improved.
- 1 January 2023
- Published by Optica Publishing Group
- p. NTu1C.3
Optimizing Imaging Throughput and Resolution in Light Sheet Microscopy Using Deep-learning-based Beam Shape Translation
A conditional generative adversarial network (cGAN) approach to optimize resolution or contrast and field-of-view (FOV) in beam-scanned light sheet microscopy by beam shape translation is demonstrated. Large FOV images acquired with collimated (pencil) beam (weakly-focused) illumination are used to predict large FOV, but higher contrast, images mimicking Gaussian-beam (highly focused) illumination. In this way, imaging throughput and resolution is improved.
- Open Access
- 22 September 2020
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 25 (09) , 096006-14
Tissue dynamics spectroscopic imaging: functional imaging of heterogeneous cancer tissue
Tumor heterogeneity presents a challenge for the successful treatment of cancer using chemotherapeutics.1 For instance, genetic variability in tumors caused by clonal outgrowth of selected genotypes within a tumor may cause subsets of cells with genetic variations to be resistant even while the majority of the tumor responds to treatment. Selective pressure and genetic drift of the cancer cell population during treatment often lead to patient relapse and the emergence of broad chemoresistance and refractory disease.2 – 4 In addition to genetic heterogeneity, there is also spatial heterogeneity in tumor tissue arising from varying tissue constituents as well as varying microenvironments, including differences in extracellular matrix and connective tissues. The tumor microenvironment5,6 and epigenetic variations5,7 – 9 pose significant challenges to the selection of treatment based on genetic profiles. This has led, as an alternative, to phenotypic profiling10 – 12 of cancer tissue that captures the systemic response of cancer tissue to applied therapy. The challenge for phenotypic profiling of cancer tissue is the need to image intact microenvironments deep inside tissue, far from surface damage caused by surgical resection, and deep inside transport-limited regions that experience hypoxia, nutrient depletion, and metabolite build-up.
- 22 September 2020
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 25 (09) , 096006-14
Open AccessTissue dynamics spectroscopic imaging: functional imaging of heterogeneous cancer tissue
Tumor heterogeneity presents a challenge for the successful treatment of cancer using chemotherapeutics.1 For instance, genetic variability in tumors caused by clonal outgrowth of selected genotypes within a tumor may cause subsets of cells with genetic variations to be resistant even while the majority of the tumor responds to treatment. Selective pressure and genetic drift of the cancer cell population during treatment often lead to patient relapse and the emergence of broad chemoresistance and refractory disease.2 – 4 In addition to genetic heterogeneity, there is also spatial heterogeneity in tumor tissue arising from varying tissue constituents as well as varying microenvironments, including differences in extracellular matrix and connective tissues. The tumor microenvironment5,6 and epigenetic variations5,7 – 9 pose significant challenges to the selection of treatment based on genetic profiles. This has led, as an alternative, to phenotypic profiling10 – 12 of cancer tissue that captures the systemic response of cancer tissue to applied therapy. The challenge for phenotypic profiling of cancer tissue is the need to image intact microenvironments deep inside tissue, far from surface damage caused by surgical resection, and deep inside transport-limited regions that experience hypoxia, nutrient depletion, and metabolite build-up.
- Open Access
Multiscale 3-dimensional pathology findings of COVID-19 diseased lung using high-resolution cleared tissue microscopy
The study of pulmonary samples from individuals who have died as a direct result of COVID-19 infection is vital to our understanding of the pathogenesis of this disease. Histopathologic studies of lung tissue from autopsy of patients with COVID-19 specific mortality are only just emerging. All existing reports have relied on traditional 2-dimensional slide-based histological methods for specimen preparation. However, emerging methods for high-resolution, massively multiscale imaging of tissue microstructure using fluorescence labeling and tissue clearing methods enable the acquisition of tissue histology in 3-dimensions, that could open new insights into the nature of SARS-Cov-2 infection and COVID-19 disease processes. In this article, we present the first 3-dimensional images of lung autopsy tissues taken from a COVID-19 patient, including 3D “virtual histology” of cubic-millimeter volumes of the diseased lung, providing unique insights into disease processes contributing to mortality that could inform frontline treatment decisions.
Open AccessMultiscale 3-dimensional pathology findings of COVID-19 diseased lung using high-resolution cleared tissue microscopy
The study of pulmonary samples from individuals who have died as a direct result of COVID-19 infection is vital to our understanding of the pathogenesis of this disease. Histopathologic studies of lung tissue from autopsy of patients with COVID-19 specific mortality are only just emerging. All existing reports have relied on traditional 2-dimensional slide-based histological methods for specimen preparation. However, emerging methods for high-resolution, massively multiscale imaging of tissue microstructure using fluorescence labeling and tissue clearing methods enable the acquisition of tissue histology in 3-dimensions, that could open new insights into the nature of SARS-Cov-2 infection and COVID-19 disease processes. In this article, we present the first 3-dimensional images of lung autopsy tissues taken from a COVID-19 patient, including 3D “virtual histology” of cubic-millimeter volumes of the diseased lung, providing unique insights into disease processes contributing to mortality that could inform frontline treatment decisions.
- Top Cited PapersOpen Access
Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series from New Orleans
SARS-CoV-2 has rapidly spread across the United States, causing extensive morbidity and mortality, though the histopathologic basis of severe disease cases has yet to be studied in detail. Over the past century, autopsy has contributed significantly to our understanding of numerous disease processes, but for several reasons, autopsy reports following deaths related to SARS- CoV-2 have thus far been limited across the globe. We report on the relevant cardiopulmonary findings in the first series of autopsies in the United States, with the cause of death being due to SARS-CoV-2 infection. These cases identify key pathologic states potentially contributing to severe disease and decompensation in these patients.
Top Cited PapersOpen AccessPulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series from New Orleans
SARS-CoV-2 has rapidly spread across the United States, causing extensive morbidity and mortality, though the histopathologic basis of severe disease cases has yet to be studied in detail. Over the past century, autopsy has contributed significantly to our understanding of numerous disease processes, but for several reasons, autopsy reports following deaths related to SARS- CoV-2 have thus far been limited across the globe. We report on the relevant cardiopulmonary findings in the first series of autopsies in the United States, with the cause of death being due to SARS-CoV-2 infection. These cases identify key pathologic states potentially contributing to severe disease and decompensation in these patients.